Table 1.

The pathological data of the discovery cohort in the study

Patient IDERHER2PRKi-67Lymph node ratioTumor subtypeTumor infiltration (%)Nontumor infiltration (%)
BC0001A3+2+20%0/16Luminal BNANA
BC0002A1++35%0/6Luminal B102
BC0003A30%1/14Basal-like200.1
BC0004A3+3+10%0/16Luminal A81
BC0005A3++2+5%1/18Luminal B0.30.1
BC0006A95%0/5Basal-like250.5
BC0007A20%0/23Basal-like21
BC0008A+40%0/29HER2 enrichedNANA
BC0009A1+30%14/18Luminal B300.1
BC0010A50%15/15Basal-like400.2
BC0011A3+2+5%0/20Luminal A80.1
BC0012A2++1+28%0/16Luminal B31
BC0013A50%0/18Basal-like20.2
BC0014A3+3+28%0/23Luminal B0.22
BC0015A60%0/5Basal-like153
BC0016A3+2+10%1/10Luminal A120.1
  • NOTE: NA means this sample was not analyzed.